Literature DB >> 33466578

Inflammatory Markers and Hepcidin are Elevated but Serum Iron is Lower in Obese Women of Reproductive Age.

Sixtus Aguree1, Manju B Reddy1.   

Abstract

Limited evidence suggests that serum iron and hepcidin concentrations are dysregulated in obesity and inflammation. The objective of the present study was to compare C-reactive protein, interleukin-6, circulating levels of hepcidin, serum lipids, and iron status in obese vs. normal-weight women of childbearing age. Healthy women aged 18-30 years were recruited for the study (n = 47: 25 obese and 22 normal weight). Fasting blood samples were obtained to measure serum lipids (total cholesterol, HDL, LDL cholesterol, triglycerides, non-HDL cholesterol), complete blood count, serum iron, total iron-binding capacity, transferrin saturation, serum ferritin, hepcidin, C-reactive protein, and interleukin-6. Obese women had significantly higher mean serum C-reactive protein (p < 0.001), interleukin-6 (p < 0.001), hepcidin (p = 0.024), triglycerides (p < 0.001) and total cholesterol/HDL ratio (p < 0.001) but lower HDL (p = 0.001) and serum iron/hepcidin ratio (p = 0.011) compared with normal-weight women. BMI correlated positively with inflammatory markers, triglycerides, LDL and total cholesterol/HDL ratio, and negatively with HDL and serum iron/hepcidin ratio. Serum iron correlated negatively with ferritin in the obese group (p = 0.030) but positively in normal weight women (p = 0.002). BMI and ferritin were the only predictors of serum iron/hepcidin ratio accounting for 23% of the variation among subjects. Studies are needed to examine anti-inflammatory dietary approaches that can improve iron biomarkers in obese women.

Entities:  

Keywords:  BMI; ferritin; hepcidin; inflammation; serum iron

Year:  2021        PMID: 33466578      PMCID: PMC7828682          DOI: 10.3390/nu13010217

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  50 in total

1.  Centrally located body fat is related to inflammatory markers in healthy postmenopausal women.

Authors:  Courtney D Perry; D Lee Alekel; Laura M Ritland; Shilpa N Bhupathiraju; Jeanne W Stewart; Laura N Hanson; Oksana A Matvienko; Marian L Kohut; Manju B Reddy; Marta D Van Loan; Ulrike Genschel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

Review 2.  Interactions between nutrition and immune function: using inflammation biomarkers to interpret micronutrient status.

Authors:  David I Thurnham
Journal:  Proc Nutr Soc       Date:  2013-10-29       Impact factor: 6.297

3.  Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.

Authors:  Erwin Kemna; Peter Pickkers; Elizabeta Nemeth; Hans van der Hoeven; Dorine Swinkels
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

4.  Assessment of iron deficiency in the context of the obesity epidemic: importance of correcting serum ferritin concentrations for inflammation.

Authors:  Agnès Gartner; Jacques Berger; Abdellatif Bour; Jalila El Ati; Pierre Traissac; Edwige Landais; Saâd El Kabbaj; Francis Delpeuch
Journal:  Am J Clin Nutr       Date:  2013-07-24       Impact factor: 7.045

Review 5.  Biomarkers of Nutrition for Development (BOND)-Iron Review.

Authors:  Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

Review 6.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

7.  The effect of central obesity on inflammation, hepcidin, and iron metabolism in young women.

Authors:  Nicole U Stoffel; Carla El-Mallah; Isabelle Herter-Aeberli; Nour Bissani; Nour Wehbe; Omar Obeid; Michael B Zimmermann
Journal:  Int J Obes (Lond)       Date:  2020-01-23       Impact factor: 5.095

8.  Joint Model of Iron and Hepcidin During the Menstrual Cycle in Healthy Women.

Authors:  Adeline Angeli; Fabrice Lainé; Audrey Lavenu; Martine Ropert; Karine Lacut; Valérie Gissot; Sylvie Sacher-Huvelin; Caroline Jezequel; Aline Moignet; Bruno Laviolle; Emmanuelle Comets
Journal:  AAPS J       Date:  2016-02-02       Impact factor: 4.009

9.  Androidal fat dominates in predicting cardiometabolic risk in postmenopausal women.

Authors:  O A Matvienko; D L Alekel; S N Bhupathiraju; H Hofmann; L M Ritland; M B Reddy; M D Van Loan; C D Perry
Journal:  Cardiol Res Pract       Date:  2010-12-19       Impact factor: 1.866

10.  Expression of the iron hormone hepcidin distinguishes different types of anemia in African children.

Authors:  Sant-Rayn Pasricha; Sarah H Atkinson; Andrew E Armitage; Shivani Khandwala; Jacobien Veenemans; Sharon E Cox; Lucy A Eddowes; Theodore Hayes; Conor P Doherty; Ayse Y Demir; Edwin Tijhaar; Hans Verhoef; Andrew M Prentice; Hal Drakesmith
Journal:  Sci Transl Med       Date:  2014-05-07       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.